NO20074528L - Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme - Google Patents

Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme

Info

Publication number
NO20074528L
NO20074528L NO20074528A NO20074528A NO20074528L NO 20074528 L NO20074528 L NO 20074528L NO 20074528 A NO20074528 A NO 20074528A NO 20074528 A NO20074528 A NO 20074528A NO 20074528 L NO20074528 L NO 20074528L
Authority
NO
Norway
Prior art keywords
same
preparation
compositions
processes
substituted pyrroles
Prior art date
Application number
NO20074528A
Other languages
English (en)
Inventor
Baptiste Ronan
Michel Tabart
Fabrice Viviani
Eric Bacque
Catherine Souaille
Pascal Desmazeau
Jean-Philippe Lettalec
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35478244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20074528(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20074528L publication Critical patent/NO20074528L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse angår substituerte pyrroler, sammensetninger som inneholder samme, en fremgangsmåte for fremstilling av samme og anvendelse derav. Spesielt angår oppfinnelsen fremstilling av substituerte pyrroler, sammensetninger som inneholder samme, en fremgangsmåte for fremstilling av samme og anvendelse derav, særlig som anti-kreftmidler.
NO20074528A 2005-02-10 2007-09-06 Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme NO20074528L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0501354A FR2881742B1 (fr) 2005-02-10 2005-02-10 Pyrroles substitues, compositions les contenant, procede de fabrication et utilisation
PCT/FR2006/000286 WO2006084996A1 (fr) 2005-02-10 2006-02-08 Pyrroles substitues compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
NO20074528L true NO20074528L (no) 2007-10-31

Family

ID=35478244

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074528A NO20074528L (no) 2005-02-10 2007-09-06 Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme

Country Status (36)

Country Link
US (1) US7592365B2 (no)
EP (1) EP1851198B1 (no)
JP (1) JP2008530061A (no)
KR (1) KR20070101317A (no)
CN (1) CN101115716A (no)
AR (1) AR052571A1 (no)
AT (1) ATE419234T1 (no)
AU (1) AU2006212106A1 (no)
BR (1) BRPI0606955A2 (no)
CA (1) CA2596822A1 (no)
CR (1) CR9231A (no)
CY (1) CY1108916T1 (no)
DE (1) DE602006004566D1 (no)
DK (1) DK1851198T3 (no)
DO (1) DOP2006000028A (no)
EA (1) EA013060B1 (no)
ES (1) ES2319926T3 (no)
FR (1) FR2881742B1 (no)
GT (1) GT200600048A (no)
HR (1) HRP20090158T1 (no)
IL (1) IL184488A0 (no)
MA (1) MA29248B1 (no)
MX (1) MX2007008789A (no)
MY (1) MY142082A (no)
NO (1) NO20074528L (no)
PA (1) PA8661601A1 (no)
PE (1) PE20061086A1 (no)
PL (1) PL1851198T3 (no)
PT (1) PT1851198E (no)
RS (1) RS50806B (no)
SI (1) SI1851198T1 (no)
TN (1) TNSN07241A1 (no)
TW (1) TW200640858A (no)
UY (1) UY29371A1 (no)
WO (1) WO2006084996A1 (no)
ZA (1) ZA200706157B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881426B1 (fr) 2005-02-03 2007-03-30 Aventis Pharma Sa Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation
NZ576291A (en) 2006-10-23 2011-10-28 Lexicon Pharmaceuticals Inc Process for preparing 5-alkyl-7h-pyrrolo[2,3-d]pyrimidine-2-ols
TW201111385A (en) 2009-08-27 2011-04-01 Biocryst Pharm Inc Heterocyclic compounds as janus kinase inhibitors
US20120244141A1 (en) 2010-09-28 2012-09-27 Boehringer Ingelheim International Gmbh Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
WO2020034988A1 (zh) * 2018-08-14 2020-02-20 江苏豪森药业集团有限公司 凋亡信号调节激酶1抑制剂的盐及其晶型
WO2020113094A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107901D0 (en) * 2001-03-29 2001-05-23 Cyclacel Ltd Anti-cancer compounds
ATE404550T1 (de) * 2001-09-21 2008-08-15 Smithkline Beecham Corp Chemische verbindungen
AU2002366440A1 (en) 2001-09-27 2003-09-09 Smithkline Beecham Corporation Chemical compounds
US20040138269A1 (en) * 2002-10-11 2004-07-15 Sugen, Inc. Substituted pyrroles as kinase inhibitors
GB0229581D0 (en) * 2002-12-19 2003-01-22 Cyclacel Ltd Use
WO2004083203A1 (en) * 2003-03-13 2004-09-30 Vertex Pharmaceuticals Incorporated Compositions useful as protein kinase inhibitors
DE10354060A1 (de) 2003-11-19 2005-06-02 Merck Patent Gmbh Pyrrolderivate
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
FR2881426B1 (fr) 2005-02-03 2007-03-30 Aventis Pharma Sa Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation

Also Published As

Publication number Publication date
CR9231A (es) 2007-10-23
KR20070101317A (ko) 2007-10-16
MA29248B1 (fr) 2008-02-01
MY142082A (en) 2010-08-30
US20080167368A1 (en) 2008-07-10
US7592365B2 (en) 2009-09-22
JP2008530061A (ja) 2008-08-07
TNSN07241A1 (en) 2008-11-21
PL1851198T3 (pl) 2009-06-30
ZA200706157B (en) 2008-11-26
TW200640858A (en) 2006-12-01
RS50806B (sr) 2010-08-31
UY29371A1 (es) 2006-10-02
PT1851198E (pt) 2009-03-26
AR052571A1 (es) 2007-03-21
DK1851198T3 (da) 2009-05-04
MX2007008789A (es) 2007-09-11
DOP2006000028A (es) 2006-09-15
WO2006084996A1 (fr) 2006-08-17
CN101115716A (zh) 2008-01-30
EP1851198A1 (fr) 2007-11-07
EA200701688A1 (ru) 2007-12-28
CA2596822A1 (fr) 2006-08-17
AU2006212106A1 (en) 2006-08-17
ATE419234T1 (de) 2009-01-15
CY1108916T1 (el) 2014-07-02
HRP20090158T1 (hr) 2009-05-31
DE602006004566D1 (de) 2009-02-12
ES2319926T3 (es) 2009-05-14
EP1851198B1 (fr) 2008-12-31
EA013060B1 (ru) 2010-02-26
PE20061086A1 (es) 2006-11-30
IL184488A0 (en) 2007-10-31
BRPI0606955A2 (pt) 2009-07-28
FR2881742B1 (fr) 2007-09-07
GT200600048A (es) 2006-07-03
PA8661601A1 (es) 2006-09-08
FR2881742A1 (fr) 2006-08-11
SI1851198T1 (sl) 2009-06-30

Similar Documents

Publication Publication Date Title
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
TW200639173A (en) Substituted pyrazolopyridines, compositions containing same, manufacturing process therefor and use thereof
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
TW200800999A (en) Novel compounds
CY1109568T1 (el) Ενωσεις βενζο(d)ισοξαζολ-3-υλαμινης και η χρησιμοποιηση τους σαν προσδεματα υποδοχεα βανιλλοειδων
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
NO20090295L (no) Substituerte heteroarylderivater
JO3408B1 (ar) مركبات بترين سلفون اميد ثيازول و أوكسازول
TW200801003A (en) Novel compounds
UA86591C2 (ru) Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе
TW200745084A (en) Novel compounds
DE602004024213D1 (en) Aminopropanolderivate
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses
TW200738659A (en) Novel compounds
NO20091990L (no) Substituerte pyrazoler, sammensetninger inneholdende disse, fremgangsmate for fremstilling og anvendelse
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
TW200745122A (en) New compounds I
GB0508314D0 (en) Organic compounds
EA200701648A1 (ru) Замещённые пирролы и имидазолы, содержащие их композиции, способ получения и применение
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
SE0300457D0 (sv) Novel compounds
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
NO20091386L (no) Fenyloksyanilinderivater
EA200870236A1 (ru) Моногидрат римонабанта, способ его получения и фармацевтические композиции на его основе
GB0615105D0 (en) Novel compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application